|
|
Line 164: |
Line 164: |
|
| |
|
|
| |
|
| ===2017: Sympathomimetic Effects of Acute E‐Cigarette Use: Role of Nicotine and Non‐Nicotine Constituents=== <!--T:35--> | | ===2017: [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5634299/#:~:text=In%20conclusion%2C%20the%20acute%20sympathomimetic,constituents%20in%20e%E2%80%90cigarette%20aerosol. Sympathomimetic Effects of Acute E‐Cigarette Use: Role of Nicotine and Non‐Nicotine Constituents]=== <!--T:35--> |
|
| |
|
| <!--T:36--> | | <!--T:36--> |
Line 173: |
Line 173: |
|
| |
|
|
| |
|
| ===2016: Cardiovascular toxicity of nicotine: Implications for electronic cigarette use=== <!--T:37--> | | ===2016: [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4958544/#:~:text=Catecholamine%20release%20from%20nicotine%20could,fibrillation%20after%20experimental%20myocardial%20infarction. Cardiovascular toxicity of nicotine: Implications for electronic cigarette use]=== <!--T:37--> |
|
| |
|
| <!--T:38--> | | <!--T:38--> |